2015 to 2019 Saw Increase in ED Use of CTPA for Suspected Pulmonary Embolism
The researchers found that from 2015 to 2019, there were significant trends for more frequent use of CTPA (836 to 1,112 per 100,000 emergency department visits).
The researchers found that from 2015 to 2019, there were significant trends for more frequent use of CTPA (836 to 1,112 per 100,000 emergency department visits).
Investigators sought to explore the relationships between clinical presentation of acute PE, patient characteristics, PE severity, and mortality.
Researchers sought to determine the use of a pulmonary embolism rule-out criteria rule and its failure rate.
Researchers determined aspirin was noninferior to LMWH for rates of mortality and pulmonary embolism in patients with a limb fracture requiring surgery or a pelvic or acetabular fracture.
Researchers sought to examine characteristics of and outcomes for patients with venothromboembolism and concomitant fibroids or gynecologic cancers.
Researchers explored the use of D-dimer levels to rule out PTE in patients with COVID-19, as well as clinical associations between D-dimer levels and PTE.
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?
New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
Researchers sought to determine whether the incidence of CAT was different across designated racial groups.
Researchers sought to determine the risk for pulmonary embolism, deep vein thrombosis, and bleeding in patients recovering from COVID-19 infection.